Only show
results from:

Sort results by:

Display preferences
77 results sorted by relevancy Results per page:
Appointments And Advancements.(Aldagen Inc. appointing David P. Carberry as chief financial officer)(AMAG Pharmaceuticals Inc. appointing Joseph V. Bonventre to its board)(Catalyst Pharmaceutical Partners Inc. appointing Patrick Kenny director of corporate clinical compliance.)
BIOWORLD Today; Mar 17, 2008; 700+ Words Adnavance Technologies Inc., of San Diego, appointed Anthony P. Bihl III to its board. Aldagen Inc., of Durham, N.C., appointed David...financial officer. Alexza Pharmaceuticals Inc., of Mountain View, Calif., named...
Aldagen and IMT Form Regenerative Medicine Alliance to Develop Revolutionary Stem Cell Purification System.
PR Newswire; Oct 11, 2006; 700+ Words ...BARBARA, Calif., Oct. 11 /PRNewswire/ -- Aldagen, Inc. and Innovative Micro Technology (IMT) today...please visit http://www.imtmems.com/. About Aldagen, Inc. Aldagen is a clinical-stage regenerative medicine company...
Aldagen IND for Stem Cell Clinical Trial to Treat Critical Limb Ischemia Is Cleared By FDA.
Business Wire; Apr 13, 2006; 700+ Words DURHAM, N.C. -- Aldagen, Inc. today announced that the U.S. Food and Drug Administration...improve the health of critical limb ischemia patients." About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique populations...
Aldagen Issued Key Stem Cell Patent; Patent Covers Unique Method of Isolating Adult Stem Cells.
Business Wire; Feb 8, 2006; 590 Words DURHAM, N.C. -- Aldagen, Inc., a company focused on regenerative medicine to treat cardiovascular...added Ed Field, President and CEO of Aldagen. About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique populations...
Interim Results of Clinical Study Using Aldagen's Product to Isolate Stem Cells from Cord Blood Presented at American Society of Hematology.
PR Newswire; Dec 11, 2006; 700+ Words ...C., Dec. 11 /PRNewswire-FirstCall/ -- Aldagen, Inc. today announced the presentation of data from...enzyme, aldehyde dehydrogenase (ALDH). About Aldagen, Inc. Aldagen is a clinical-stage regenerative medicine company...
Aldagen to Present at BioDevice Partnering 2006.
PR Newswire; Jun 7, 2006; 629 Words DURHAM, N.C., June 7 /PRNewswire/ -- Aldagen, Inc. today announced that Tom Amick, Chairman and...one-on-one meetings in private booths. About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique...
Aldagen Announces Texas Heart Institute as First Site in its Stem Cell Clinical Trial to Treat Critical Limb Ischemia.
PR Newswire; Dec 15, 2006; 700+ Words DURHAM, N.C., Dec. 15 /PRNewswire/ -- Aldagen, Inc. today announced that the Texas Heart Institute...supply to ischemic leg by less invasive means. About Aldagen, Inc. Aldagen is a clinical-stage regenerative medicine company...
StemCo Biomedical Changes Name to Aldagen, Inc.; Name Change Reflects Company's Focus in Regenerative Medicine.
Business Wire; Nov 29, 2005; 584 Words ...today announced that it has changed its name to Aldagen, Inc. The change was made to reflect more accurately...member of Aldagen's Board of Directors. About Aldagen, Inc. Aldagen is developing and commercializing proprietary products...
Aldagen and Texas Heart Institute to Begin Clinical Study of Stem Cell Therapy for Advanced Heart Failure Patients; FDA Clears IND to Begin Clinical Study.
Business Wire; Feb 21, 2006; 700+ Words DURHAM, N.C. -- Aldagen, Inc. today announced that the U.S. Food and Drug Administration...mail directly to plea@heart.thi.tmc.edu. About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique populations...
Aldagen Wins SPA for Trial with Stem Cells in Ischemia.
BIOWORLD Today; Aug 6, 2009; ; 700+ Words ...Washington Editor Privately held Aldagen Inc. has reached an agreement under...and ultimately commercialize it." Aldagen has not disclosed the primary endpoint...the trial of ALD-301 would be Aldagen's second Phase III stem cell therapy...
Aldagen's Products Isolate Human Adult Stem Cells that Can Regenerate Vascular Function; Preclinical Data Presented at the American Society of Hematology 2005.
Business Wire; Dec 12, 2005; 700+ Words DURHAM, N.C. -- Aldagen, Inc. today announced that researchers from the Washington University...added Ed Field, President and CEO of Aldagen. About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique populations...
Aldagen's Product Used to Isolate Stem Cells from Cord Blood in Human Clinical Study; Initial Safety Demonstrated in Clinical Study at Duke University Medical School.
Business Wire; Mar 22, 2006; 700+ Words DURHAM, N.C. -- Aldagen, Inc. today announced that clinicians at Duke University Medical...certain tissue repair and regeneration applications." About Aldagen, Inc. Aldagen's proprietary products identify and isolate unique populations...
Despite Tough Market, Aldagen's IPO Seeks $81M for Cell Therapy.
BIOWORLD Today; May 13, 2008; ; 700+ Words ...program in a pivotal study, Aldagen Inc. has decided to brave...offered or share price. Aldagen is seeking a Nasdaq listing...Fla.-based Bioheart Inc.'s paltry $5.8 million...In its prospectus, Aldagen said proceeds from the...
Financings Roundup Cell Therapy Company Aldagen Adds $9M To Series C Financing.
BIOWORLD Today; Sep 14, 2007; ; 700+ Words ...cell therapy products, Aldagen Inc. padded its bank account...total to $23 million. Aldagen's Series C initially...unique opportunity," for Aldagen, Field said, and the...Francisco-based Exelixis Inc. closed its previously...
Aldagen Eyes Public Markets to Fund Two Phase III Efforts.
BIOWORLD Today; Oct 30, 2009; 597 Words ...discussions under way, Aldagen Inc. has renewed its efforts...to additional testing. Aldagen, formerly named as StemCo...venture capital funding. Aldagen is the latest in what...Cumberland Pharmaceuticals Inc. became the first drugmaker...
Aldagen wins SPA for stem cells in ischemia.(Thursday, August 6)
BioWorld Week; Aug 10, 2009; 455 Words Privately held Aldagen Inc. has reached an agreement under a special...fund the study, the company said. Aldagen has not disclosed the primary endpoint...way, the trial of ALD-301 would be Aldagen's second Phase III stem cell therapy...
Included among recent SEC filings for initial public offerings, Aldagen Inc. (Durham NC) registered up to $80.5 million worth of common stock via Cowen & Company.(IPO Sector)(Securities and Exchange Commission)(Brief article)
MondayMorning; May 19, 2008; 700+ Words ...filings for initial public offerings, Aldagen Inc. (Durham NC) registered up to...can target a number of diseases. Aldagen hopes its products will be used to...treatments that receive FDA approval. Aldagen was formed in 2000 under the name...
Included among SEC filings for initial public offerings, Aldagen Inc. (Durham NC) registered up to $80.5 million worth of common stock via underwriter Cowen & Company LLC.(IPO Sector)
MondayMorning; Nov 2, 2009; 700+ Words ...filings for initial public offerings, Aldagen Inc. (Durham NC) registered up to...can target a number of diseases. Aldagen hopes its products will be used to...Intersouth Partners holds about 42% of Aldagen. The company is led by CEO W. Thomas...
North Carolina biotechnology directory 2009.(Adherex Technologies Inc.)(Applied Pharma Research)(Array BioPharma Inc.)(Directory)
Business North Carolina; Sep 1, 2009; 700+ Words ...8003 (919)413-7647 www.alaeras.com Aldagen Inc. 2810 Meridian Parkway Suite 148 Durham, NC 27713 (919)484-2571 www.aldagen.com Alderon Biosciences Inc. 594 Sea Gate Drive Newport, NC 28570 (252...
Other News To Note.(briefs)(Abraxis BioScience Inc.)
BIOWORLD Today; Jul 3, 2007; 700+ Words ...Development. Albany Molecular Research Inc., of Albany, N.Y., has completed...capabilities over the next three years. Aldagen Inc., of Durham, N.C., has established...and quality control activities. Aldagen's proprietary stem cell isolation...
77 results: 1 | 2 | 3 | 4

Find articles, research, and archives